Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Purchase |
2024-12-31 | 13G | Apogee Therapeutics, Inc. APGE |
RTW Investments, LP | 2,712,097 6.000% |
2,712,097 (New Position) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
RA Capital Management, L.P. | 1,961,863 3.400% |
-16,038 (-0.81%) |
Filing History |
| 2024-11-14 11:16 am Purchase |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
DRIEHAUS CAPITAL MANAGEMENT INC | 2,533,607 5.630% |
2,533,607 (New Position) |
Filing History |
| 2024-11-14 10:18 am Sale |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 1,000,000 2.220% |
-1,323,456 (-56.96%) |
Filing History |
| 2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | Apogee Therapeutics, Inc. APGE |
FMR CORP | 7,502,482 16.672% |
2,483,602 (+49.49%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
BLACKROCK INC BLK |
2,975,917 6.600% |
0 (Unchanged) |
Filing History |
| 2024-11-04 7:59 pm Purchase |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
Access Industries Management, LLC | 2,190,364 4.870% |
250,000 (+12.88%) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
BLACKROCK INC BLK |
2,975,917 6.600% |
2,975,917 (New Position) |
Filing History |
| 2024-10-04 10:05 am Purchase |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
WELLINGTON MANAGEMENT CO LLP | 4,814,400 10.700% |
4,814,400 (New Position) |
Filing History |
| 2024-04-01 5:42 pm Sale |
2024-03-28 | 13D | Apogee Therapeutics, Inc. APGE |
Fairmount Funds Management LLC | 4,762,558 9.990% |
-640,495 (-11.85%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Apogee Therapeutics, Inc. APGE |
RA Capital Management, L.P. | 1,977,901 5.300% |
1,977,901 (New Position) |
Filing History |
| 2024-02-14 08:35 am Sale |
2023-12-31 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 2,323,456 6.250% |
-700,000 (-23.15%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Apogee Therapeutics, Inc. APGE |
FMR CORP | 5,018,880 13.496% |
570,979 (+12.84%) |
Filing History |
| 2024-01-31 4:30 pm Purchase |
2024-01-29 | 13D | Apogee Therapeutics, Inc. APGE |
Fairmount Funds Management LLC | 5,403,053 9.990% |
1,496,851 (+38.32%) |
Filing History |
| 2023-11-03 4:01 pm Purchase |
2023-10-24 | 13G | Apogee Therapeutics, Inc. APGE |
Access Industries Management, LLC | 1,940,364 5.220% |
1,940,364 (New Position) |
Filing History |
| 2023-08-10 08:19 am Purchase |
2023-08-09 | 13G | Apogee Therapeutics, Inc. APGE |
FMR CORP | 4,447,901 12.094% |
4,447,901 (New Position) |
Filing History |
| 2023-07-28 4:15 pm Purchase |
2023-07-18 | 13D | Apogee Therapeutics, Inc. APGE |
Venrock Healthcare Capital Partners III L.P. | 3,887,478 9.990% |
3,887,478 (New Position) |
Filing History |
| 2023-07-24 4:05 pm Purchase |
2023-07-14 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 3,023,456 8.870% |
3,023,456 (New Position) |
Filing History |
| 2023-07-21 4:31 pm Purchase |
2023-07-13 | 13D | Apogee Therapeutics, Inc. APGE |
Fairmount Funds Management LLC | 3,906,202 9.990% |
3,906,202 (New Position) |
Filing History |